BridgeBio Pharma, Inc. (BBIO)

NasdaqGS • Currently down 0.67 (-0.83%) in today's trading session

1 member of Congress has disclosed 7 trades in BridgeBio Pharma, Inc. (BBIO) via STOCK Act filings. The most recent disclosure was a purchase by Gilbert Cisneros on 11 May 2026. Aggregate disclosed activity totals roughly $56K in purchases (midpoint estimates from bracketed disclosure amounts).

BridgeBio Pharma, Inc. is currently trading at $80.40, positioned at 71% of its 52-week range ($48.78 – $93.42).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Portfolio

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$80.40
24h Change
-0.67 (-0.83%)
52 Week Range
$48.78—$93.42
View on NASDAQ

BridgeBio Pharma, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for BBIO

Select to highlight on chart
7 transactions
Compliance: 100%
Gilbert Cisneros11 May 20268 Jun 2026PurchaseStock$1,001 - $15,000+24.30%
Gilbert Cisneros29 Apr 20268 May 2026PurchaseStock$1,001 - $15,000+15.33%
Gilbert Cisneros19 Mar 20267 Apr 2026PurchaseStock$1,001 - $15,000+14.66%
Gilbert Cisneros18 Mar 20267 Apr 2026PurchaseStock$1,001 - $15,000+13.34%
Gilbert Cisneros3 Mar 20267 Apr 2026PurchaseStock$1,001 - $15,000+22.75%
Gilbert Cisneros22 Sept 202510 Oct 2025PurchaseStock$1,001 - $15,000+56.00%
Gilbert Cisneros8 Aug 202512 Sept 2025PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$15.75B

Volume

1.47M

Beta

0.98

P/E Ratio

-21.50

Fundamentals

EPS

$-3.74

Div. Yield

—

Open

$81.89

Day Range

$80.20 — $82.50

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Neil Kumar
IPO Date
2019-06-27
Website
www.bridgebio.com

BridgeBio Pharma, Inc. is a pharmaceutical company dedicated to identifying, advancing, and providing medical solutions for various genetic conditions. The firm boasts an extensive portfolio comprising 30 distinct development initiatives, spanning th...

Earnings

Next Report

Q3 2026

28 Oct

EPS Est.

$-0.62

Rev. Est.

$267.3M

Days Until

63

Recent Quarters

Q2 202610 Aug
EPS$-0.78
Miss 35.5%
Q1 20267 May
EPS$-0.84
Miss 23.8%
Q4 202524 Feb
EPS$-1.00
Miss 40.2%
Q3 202529 Oct
EPS$-0.95
Miss 8.0%
Q2 20255 Aug
EPS$-0.95
Miss 14.5%
Q1 202529 Apr
EPS$-0.88
Beat 12.0%
Q4 202420 Feb
EPS$-1.31
Miss 20.2%
Q3 202412 Nov
EPS$-0.86
Beat 16.5%
Q2 20241 Aug
EPS$-1.02
Beat 6.4%
Q1 20242 May
EPS$-0.20
Beat 71.8%
Q4 202322 Feb
EPS$-0.96
Miss 1.1%
Q3 20232 Nov
EPS$-1.08
Miss 25.6%
Q2 20233 Aug
EPS$-0.98
Miss 13.9%
Q1 20234 May
EPS$-0.92
Miss 9.5%
Q4 202223 Feb
EPS$-0.87
Miss 1.2%
Q3 20223 Nov
EPS$-0.93
Beat 8.8%
Q2 20224 Aug
EPS$-0.81
Beat 12.0%
Q1 20225 May
EPS$-1.19
Miss 5.3%
Q4 202124 Feb
EPS$-1.01
Miss 21.7%
Q3 20214 Nov
EPS$-1.06
Miss 16.5%
Q2 20215 Aug
EPS$-0.66
Beat 29.0%
Q1 20216 May
EPS$-1.18
Miss 35.6%
Q4 202025 Feb
EPS$-1.01
Miss 17.4%
Q3 20205 Nov
EPS$-0.98
Miss 1.0%
Q2 202011 Aug
EPS$-1.03
Miss 30.4%
Q1 202013 May
EPS$-0.78
Miss 13.0%
Q4 20192 Mar
EPS$-0.62
Beat 11.4%
Q3 20197 Nov
EPS$-0.51
Beat 7.3%
Q2 201914 Aug
EPS$-3.46
Miss 565.4%
Q1 201928 Jun
EPS$-0.42
Q4 201831 Mar
EPS$-0.51
Q2 201830 Sept
EPS$-0.34
Q1 201830 Jun
EPS$-0.29
Q4 201731 Mar
EPS$-0.37

1 politician traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

AAPL

Apple Inc.

22
$309.90-0.44 (-0.14%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

SPY

State Street SPDR S&P 500 ETF Trust

17
$765.91+2.44 (+0.32%)
Financial Services
Held by same politician
1 politician
View Stock

WBI

WaterBridge Infrastructure LLC

17
$31.79+0.31 (+0.98%)
Energy
Held by same politician
1 politician
View Stock

Frequently Asked Questions about BBIO

Which members of Congress have traded BBIO?
1 member of Congress has disclosed 7 trade in BridgeBio Pharma, Inc. (BBIO) under the STOCK Act: Gilbert Cisneros.
When was BBIO most recently disclosed by Congress?
The most recent BBIO disclosure was a purchase by Gilbert Cisneros on 11 May 2026.
What is the total disclosed congressional trading volume for BBIO?
Members of Congress have disclosed approximately $56K in BBIO purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in BBIO?
This BBIO page updates as soon as new STOCK Act disclosures are filed for BridgeBio Pharma, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.